By Michael Dabaie

 

Corning Inc. and Pfizer Inc. said they are in a long-term purchase and supply agreement for Corning Valor Glass.

The multiyear agreement is for the supply of Valor Glass vials to a portion of currently marketed Pfizer drug products, pending regulatory approval.

The companies said that since first launching its collaboration with Corning, Pfizer has continued to evaluate Valor Glass' performance across several aseptic sites, using multiple vial sizes, with a broad range of sterile injectables drug products.

Valor Glass was provisionally evaluated under the Food and Drug Administration's Emerging Technology Program.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

(END) Dow Jones Newswires

May 28, 2020 09:15 ET (13:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Pfizer.
Pfizer (NYSE:PFE)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Pfizer.